CVKD
Cadrenal Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$7.40
+0.22 ▲ +3.06%
🌙 3월 13일 5:50 PM ET (한국 3/14 06:50)
$7.66
+0.26 ▲ +3.51%
| Index | - | P/E | - | EPS (ttm) | -8.01 | Insider Own | 22.37% | Shs Outstand | 0.00B | Perf Week | -10.63% |
| Market Cap | 0.02B | Forward P/E | - | EPS next Y | 33.81% | Insider Trans | -8.49% | Shs Float | 0.00B | Perf Month | 29.82% |
| Enterprise Value | 0.01B | PEG | - | EPS next Q | -1.17 | Inst Own | 5.2% | Short Float | 6.06% | Perf Quarter | -33.39% |
| Income | -0.01B | P/S | - | EPS this Y | 27.15% | Inst Trans | 1.13% | Short Ratio | 1.84 | Perf Half Y | -45.19% |
| Sales | 0.00B | P/B | 5.57 | EPS next 5Y | 35.34% | ROA | -328.18% | Short Interest | 0.11M | Perf YTD | 9.14% |
| Book/sh | 1.33 | P/C | 4.48 | EPS past 3/5Y | -0.45% - | ROE | -468.03% | 52W High | -63.71% ($20.39) | Perf Year | -57.59% |
| Cash/sh | 1.65 | P/FCF | - | Sales past 3/5Y | - | ROIC | -525.99% | 52W Low | 50.71% ($4.91) | Perf 3Y | -68.17% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -9.8% | Gross Margin | - | Volatility(W/M) | 7.87% 9.74% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.66 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 2.95 | EPS Q/Q | 39.76% | Profit Margin | - | RSI (14) | 49.08 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.95 | Sales Q/Q | - | SMA20 | -0.47% ($7.43) | Beta | 1.19 | Target Price | $35 |
| Payout | - | Debt/Eq | 0 | Earnings | 11000000 | SMA50 | 2.3% ($7.23) | Rel Volume | 0.43 | Prev Close | $7.18 |
| Employees | 4 | LT Debt/Eq | 0 | EPS/Sales Surpr. | 15.48% - | SMA200 | -31.98% ($10.88) | Avg Volume(3M) | 0.06M | Price | $7.4 |
| IPO | 2023/1/20 | Option/Short | No/Yes | Trades | 383 | Volume | 25,678 | Change | 3.06% |
뉴스 로딩 중...